Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºÒÀÀ¼º ³­¼Ò¾Ï ȯÀÚ¿¡¼­ÀÇ Paclitaxel/Ifosfamide Åõ¿©¿¡ ´ëÇÑ Á¦1»ó Àӻ󿬱¸ Phase I Clinical Trial of Paclitaxel Plus Ifosfamide for the Patients with Refractory Ovarian Cancer

´ëÇѾÏÇÐȸÁö 2000³â 32±Ç 5È£ p.895 ~ 903
¼­È£¼®, ÀÌÀç°ü,
¼Ò¼Ó »ó¼¼Á¤º¸
¼­È£¼® (  ) 
°í·Á´ëÇб³

ÀÌÀç°ü (  ) 
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç

Abstract


Ovary neoplasm; Chemotherapy; Phase I; Paclitaxel; Ifosfamide; Dose limiting toxicity; Maximum tolerated dose;

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS